ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?
Key PointsPfizer's CEO thinks his company will make big waves in the weight loss market.
Announcement as on 18 November 2025

Patent expiry looms: Eli Lilly and Novo Nordisk strategise to defend their top obesity drugs in India
Eli Lilly and Novo Nordisk leaders share their India strategies for weight-loss drugs. They focus on pricing, market expansion and countering generics after semaglutide's patent ends. Both companies aim to increase patient access to their innovative thera
Announcement as on 18 November 2025

Why cutting drug prices is pushing Eli Lilly’s stock to all-time highs

Announcement as on 12 November 2025

Eli Lilly drops CVS drug plan for staff after Novo obesity deal: Report
Eli Lilly is switching its employee drug benefit plan from CVS Health to Rightway, a move reportedly linked to CVS's decision to stop covering Lilly's weight-loss drug Zepbound in favor of Novo Nordisk's Wegovy. Lilly stated the change was due to Rightway
Announcement as on 12 November 2025

Eli Lilly's Zepbound Single-dose Vials To Be Available At Walmart Pharmacies From Mid-November
(RTTNews) - Eli Lilly and Company (LLY)/, Wednesday announced a collaboration with Walmart Inc. (WMT) to expand access to direct-to-consumer pricing for Zepbound (tirzepatide) single-dose vials available through LillyDirect.
Announcement as on 29 October 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1007.53
  • 12Day Average: 1046.45
  • 20Day Average: 1037.87
  • 50Day Average: 914
  • 100Day Average: 825.33
  • 150Day Average: 806.38
  • 200Day Average: 811.31

LLY Indicators & signals

Indicator MACD (12,26,9)

1022.48, 995.58, 44.18
Indicator MACD is in positive zone

Indicator ADX (14)

14.55, 20.83, 27.92
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Tue Dec 2025 982.22 979.18 to 1012.00 -1.54% 1.02 times
08 Mon Dec 2025 997.59 988.88 to 1014.20 -1.21% 1.22 times
05 Fri Dec 2025 1009.77 1004.00 to 1027.39 -0.47% 0.51 times
04 Thu Dec 2025 1014.49 1007.18 to 1032.63 -1.85% 1.54 times
03 Wed Dec 2025 1033.56 1022.32 to 1051.48 -1.13% 1.37 times
02 Tue Dec 2025 1045.37 1040.36 to 1068.18 -1.18% 0.67 times
01 Mon Dec 2025 1057.89 1055.00 to 1084.15 -1.63% 1.22 times
28 Fri Nov 2025 1075.47 1067.69 to 1099.05 -2.67% 1.09 times
26 Wed Nov 2025 1104.92 1098.10 to 1119.15 -0.42% 0.55 times
25 Tue Nov 2025 1109.59 1065.99 to 1111.11 4% 0.92 times
24 Mon Nov 2025 1066.88 1000.01 to 1075.72 0.68% 0.9 times
21 Fri Nov 2025 1059.70 1038.00 to 1066.65 1.57% 1.7 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

 

Back to top